CISPLATIN for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 95 adverse event reports in the FDA FAERS database where CISPLATIN was used for Prostate cancer.
Most Reported Side Effects for CISPLATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 4,359 | 9.2% | 746 | 1,415 |
| Disease progression | 3,746 | 7.9% | 880 | 500 |
| Neutropenia | 3,095 | 6.5% | 464 | 920 |
| Febrile neutropenia | 3,010 | 6.3% | 580 | 1,580 |
| Nausea | 2,923 | 6.2% | 282 | 1,470 |
| Drug ineffective | 2,608 | 5.5% | 744 | 607 |
| Thrombocytopenia | 2,565 | 5.4% | 410 | 911 |
| Anaemia | 2,530 | 5.3% | 338 | 1,111 |
| Vomiting | 2,326 | 4.9% | 286 | 1,314 |
| Diarrhoea | 2,022 | 4.3% | 376 | 1,069 |
| Malignant neoplasm progression | 2,004 | 4.2% | 726 | 446 |
| Pyrexia | 1,863 | 3.9% | 243 | 1,263 |
| Myelosuppression | 1,849 | 3.9% | 106 | 843 |
| Acute kidney injury | 1,783 | 3.8% | 279 | 1,162 |
| Fatigue | 1,394 | 2.9% | 161 | 561 |
Other Indications for CISPLATIN
Diffuse large b-cell lymphoma (2,703)
Product used for unknown indication (2,614)
Non-small cell lung cancer (1,762)
Plasma cell myeloma (1,239)
Oesophageal carcinoma (1,094)
Lung adenocarcinoma (1,003)
Lung neoplasm malignant (988)
Osteosarcoma (975)
Chemotherapy (958)
Cholangiocarcinoma (923)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)